<DOC>
	<DOCNO>NCT00641329</DOCNO>
	<brief_summary>The purpose study determine CLONICEL ( clonidine HCl sustain release ) safe effective add-on psychostimulant therapy child adolescent attention deficit hyperactivity disorder ( ADHD ) .</brief_summary>
	<brief_title>CLONICEL ( Clonidine Sustained Release ) Add-on Stimulant Medication 6 17 Yr-olds With ADHD</brief_title>
	<detailed_description />
	<mesh_term>Clonidine</mesh_term>
	<criteria>Age 617 year , inclusive Diagnosis ADHD Currently stable psychostimulant regimen ADHD Lack adequate response stable psychostimulant regimen Ability swallow tablet Clinically significant illness abnormality upon evaluation Conduct Disorder Intolerance clonidine History seizures syncope</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>ADHD</keyword>
	<keyword>ADD</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>Attention Deficit</keyword>
	<keyword>Clonidine</keyword>
	<keyword>CLONICEL</keyword>
	<keyword>Addrenex</keyword>
</DOC>